Active Ingredient: Azithromycin
Sanford guide to antimicrobial therapy. Azithromycin and the risk of cardiovascular death. This is the first observational study that accessed the cardiac risks and raised increased concern of cardiac risks of azithromycin.
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.
Ann Fam Med. This is the most recently published study evaluating the cardiac risks of azithromycin and levofloxacin. Federal Drug Comission. The Pink Sheet.
Chevy Chase, MD: 1999. FDA Statement regarding azithromycin Zithromax and the risk of cardiovascular death.
Use of azithromycin and death from cardiovascular causes. This observational study examined the cardiac risks of azithromycin in patients aged 18 — 64. Bazett HC.
An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardiol. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
J Am Coll Cardiol.
Risk stratification in the long-QT syndrome. Roden DM. Drug-induced prolongation of the QT interval.
Long QT syndromes and torsade de pointes. Empty zinc levels well maintained by zinc supplementation will therefore assist stop the severity multiplying of viruses. Chloroquine has been reported for malaria treatment and chemoprophylaxis, though there were above reviews of hydroxychloroquine being feeding successfully to deal with SARS, whereas erythromycin and clarithromycin attempted.